Brain transplantation of genetically corrected Sanfilippo type B neural stem cells induces partial cross-correction of the disease
Open Access
- 27 October 2022
- journal article
- research article
- Published by Elsevier in Molecular Therapy - Methods & Clinical Development
- Vol. 27, 452-463
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 50 references indexed in Scilit:
- Disease correction by combined neonatal intracranial AAV and systemic lentiviral gene therapy in Sanfilippo Syndrome type B miceGene Therapy, 2013
- Necrotizing Sweet syndrome: A new variant of neutrophilic dermatosis mimicking necrotizing fasciitisJournal of the American Academy of Dermatology, 2012
- Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIBPLOS ONE, 2012
- Lysosomal fusion and SNARE function are impaired by cholesterol accumulation in lysosomal storage disordersThe EMBO Journal, 2010
- Structural Plasticity and Hippocampal FunctionAnnual Review of Psychology, 2010
- Neural Stem Cell Transplantation Benefits a Monogenic Neurometabolic Disorder During the Symptomatic Phase of DiseaseStem Cells, 2009
- Lysosomal accumulation of SCMAS (subunit c of mitochondrial ATP synthase) in neurons of the mouse model of mucopolysaccharidosis III BMolecular Genetics and Metabolism, 2007
- Clinical response to persistent, low‐level β‐glucuronidase expression in the murine model of mucopolysaccharidosis type VIIJournal of Inherited Metabolic Disease, 2007
- Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 miceJournal of Comparative Neurology, 2006
- Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic–ischemic brain injuryExperimental Neurology, 2006